Supramolecular complex of fluoxetine with beta-cyclodextrin: an experimental and theoretical study.
In this work the complex formed between beta-cyclodextrin (betaCD) and fluoxetine (FLU) was investigated by experimental and computational methods. From Horizontal Attenuated Total Reflectance (HATR) was possible to verify a strong modification in the vibrational modes of betaCD and FLU, indicating interactions between them. The Nuclear Magnetic Resonance (NMR) experiments confirm these interactions through the change in chemical shifts in (1)H spectra, reduction in longitudinal relaxation times values, and the Nuclear Ouverhauser Effect confirm the inclusion of aromatic rings of FLU into the betaCD. The structures of the proposed inclusion compounds were optimized at PM3 semiempirical level of theory. In addition, single point calculations at the Density Functional Theory (DFT) level, using the Becke, Lee, Yang, and Parr functional and 6-31G(d,p) basis set, were used to determine the interaction energy for these structures. The DFT calculations identified the aromatic ring, which contains the CF(3) group as the most stable into the betaCD by an amount of, 11.7 kcal mol(-1), in the gas phase. Polarized continuum model, at the DFT level mentioned, was used to investigate the solvent effect, and the results corroborated the gas phase analysis. A high equilibrium constant (K approximately 6921+/-316) and the stoichiometry, 1:1, were obtained by Isothermal Titration Calorimetry (ITC) experiments.
de Sousa
Frederico B
FB
Laboratório de Encapsulamento Molecular e Biomateriais (LEMB), Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Denadai
Angelo M Leite
AM
Lula
Ivana S
IS
Lopes
Juliana F
JF
Dos Santos
Hélio F
HF
De Almeida
Wagner B
WB
Sinisterra
Rubén D
RD
D005473:Fluoxetine / Q000008:administration & dosage / Q000737:chemistry*; D009682:Magnetic Resonance Spectroscopy; D012031:Refractometry; D017550:Spectroscopy, Fourier Transform Infrared; D013816:Thermodynamics; D047392:beta-Cyclodextrins / Q000008:administration & dosage / Q000737:chemistry*
D047392:beta-Cyclodextrins; D005473:Fluoxetine; C031215:betadex